AI analysis of skin images for basal cell carcinoma risk
Part of Cancer, Skin clinical trials.
This study uses artificial intelligence to analyze magnified skin images of basal cell carcinoma to predict the cancer's subtype and risk classification. It aims to improve diagnosis and treatment planning without additional procedures.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with basal cell carcinoma through a skin biopsy.
- The specific subtype of your cancer is known from the biopsy report.
- High-quality magnified images (dermoscopic photos) of your tumor are available.
- You are at least 18 years old (implied, not stated but common).
- You have not had treatment that would affect the appearance of the tumor before imaging (assumed).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a special microscope that uses artificial intelligence (AI) to help surgeons see exactly where skin cancer (basal cell carcinoma) ends during surgery. This could help remove all cancer cells in one go, making repeat surgeries less likely.
This study is testing whether an artificial intelligence (AI) system can accurately diagnose basal cell carcinoma, a common type of skin cancer, from microscope slide images. If you have had a biopsy slide of a skin lesion that was already diagnosed as basal cell carcinoma, your sample might be used to help train or test the AI.
This study tests an AI-enhanced imaging technique to help doctors see the edges of a common type of skin cancer called basal cell carcinoma before surgery. It may help ensure the cancer is removed completely the first time.
This trial tests an artificial intelligence (AI) system that helps doctors decide if a skin lesion might be cancer. If you are seeing your primary care doctor about a mole or spot that concerns them or you, this study might be for you.
This trial uses artificial intelligence to help diagnose seborrheic keratosis, a common harmless skin growth. It aims to see if the AI can accurately identify these growths from skin samples, which could help doctors make faster and more reliable diagnoses.
This study uses artificial intelligence to help detect melanoma (a type of skin cancer) and predict risk in children, teens, and young adults. Researchers want to see if AI can spot melanoma early and assess risk better.
Hear when a new Basal Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.